Reddit Posts
Biovaxys symbols $BIOV on the Canadian Venture and OTC $BVAXF
Mentions
I see it the same way. Sometimes the quiet players, like $BIOV / $BVAXF, are the ones worth tracking.
I agree with you there. Financing structures like this remind me of how $BIOV / $BVAXF approached their last raise.
Holding $BIOV $BVAXF as a high-upside flyer, just in case it hits big.
PHRRF, SNANF, BVAXF are long term for me!
Forgot to mention $PHRRF & $BVAXF
$PHRRF & $BVAXF will make us rich!
Why is no one talking about $PHRRF? Or $BVAXF? So much good news!
I'm about to invest in $PHRRF and $BVAXF for long-term.
$BIOV $BVAXF got some solid biotech potential
Check out BIOV/BVAXF, innovative biotech with serious growth potential
MDXXF, RVVTF, MSCLF, BVAXF I plan to hold most of these for the long term, along with ELTP, and ATAI
Biovaxys. $BVAXF US OTC. $BIOV Canada. Watch recent spaces interview on YouTube: https://youtu.be/jS09q8WwBPw?si=tqJfvgPOAaesUFwl Vaccine Lipid Delivery System=Dpx. About to break out. Invited to present at Cancer Summit in Boston 12-3 to 12-5. Actively seeking licensing or partnership on phase 3 MVP-S Ovarian Cancer. And Phase 1complete DPX RSV vaccine. These guys bought assets of IMV (BANKRUPT). IMV did not recognize DPX delivery system was their product, not the cancer drug (MVP-S) they put inside it and wasted all their money on. Looking for huge potential - do a deep dive on this fascinating company. Zacks interview is good too: https://onlinexperiences.com/scripts/Server.nxp?LASCmd=L:0&AI=1&ShowKey=262963&LoginType=0&InitialDisplay=1&ClientBrowser=0&DisplayItem=NULL&LangLocaleID=0&MobileSiteLogin=1&SSO=1&RFR=https://onlinexperiences.com/Launch/Event.htm?ShowKey=262963&EmbedTest=NULL&RandomValue=1726841277648
$BVAXF, $PURR and $INVR are my top 3 right now
BVAXF, please and thank you.
1). It is just under the radar. There is a group on CEO.CA & Stocktwits. I got on Reddit to spread the word and hoping I'm looking for a new bioplay soon. 2). Ken Kovan, COO, is on LinkedN. I deep dive stuff & Passin has been active in Mongolia. I believe he married a Mongolian woman in 2017. There are YouTube interviews with him and a few articles if you Google. Passin has a Twitter, but doesn't really tweet. He has been called a renegade & Indiana Jones. Old article about uranium shows this level of profitability. 3). The $1 million did acquire, but also Horizon (creditor) gets $25 million (basically on sale) or if their profit sharing is bought out, and there are milestone payments etc. They also got like 3.7 million shares which we estimate (my husband and I) will go for $1-$5 - depending on the sale amount. That could put them around $40 million. I don't know if he had a connection or possibly Maxim Group investment bankers did. The lender will be happy to get their $25 million back. Although we have done well with biotech plays (Ocugen, Prog), this would be the penultimate one. We first bought BVAXF at fifty cents & have been accumulating for a couple years. Hard to dig a pennystock out. But I really believe Passin has been searching for a failed biotech to merge into bvaxf. This one is a crazy synergistic fit. My spouse is a rather brilliant scientist (non-medical). I found the stock originally and he ran with it accumulating (had a feeling). So partly me, mostly him, and, if it does what it appears to be doing, a bit of luck. I'm on my phone & can't see your original post, but will check it in the am again. Obviously you never know with Biotech, but having played in it a lot, this one is certainly different. I've been screaming acquisition as I see this as their best option, and the tweets lately from bvaxf are backing that up. I think it could happen soon but spouse did think longer but now thinks 2024.
I'm heavily invested in BVAXF (BIOV Canada). It is seven cents a share. $15 million market cap. Read attached detailed article. BIOVAXYS' BARGAIN BONANZA: SEIZING A BIOTECH TREASURE TROVE FROM IMV'S ASHES Just when I had given up hope that $BVAXF, would thrive, they acquired all the intellectual property of bankrupt IMV from a secured creditor for only $1 million. At it's peak IMV had a market cap of $.33 billion. See IMV SCIENCE CHANNEL on YouTube. Watch the short videos. They plan to pursue licensing & partnerships. I plan to hold 1-2 years, unless big pharma swoops them up sooner. Very under the radar. Acquisition just completed & their biotech conference dog & pony show should begin soon. Hoping the killer whale pharmas start fighting over it. CEO is an investment banker. No salary - just stock so he's motivated with a strong history of success. Great detailed article. I'm looking for $1.25+ [Biovaxys seizes treasure trove from IMV assets](https://www.medicalgold.ca/posts/biovaxys-bargain-bonanza-seizing-a-biotech-treasure-trove-from-imvs-ashes)
My husband and I have been accumulating $bvaxf for 2 years. The IMV deal is a big cherry on top. BVAXF had been pretty quiet in 2023. They were obviously focused on this deal. They bought a software company & divested it within months and we were thinking "what are they doing?". In hindsight, they were making this deal happen. Then this hit & we added another 25% shares to our position. We've hit and missed with biotech. We are feeling good about this one. If this hits, we retire in style.
OTC in US under BVAXF Biovaxys. I'm e-trade, but I would assume yes.
$BVAXF $BIOV (CANADA). .0671 US. UP FROM 1 CENT Just completed (today) acquisition of all defunct IMV intellectual property. Cap $13.8 million. Biovaxys statement: At its peak, NASDAQ-listed IMV INC's market cap of US$0.33B and share price of US$59.50 reflects the high-value investors put on its technological innovations, pipeline & commercial potential. This historical benchmark projects potential capitalization for $BIOV post-acquisition I'm holding for big pharma licensing deals but hoping for buyout.
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC. @newswire/biovaxys-completes-the-acquisition-of-all-intellectual-4b459 $5LB $BIOV $BVAXF.US
News release just now: BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC. @newswire/biovaxys-completes-the-acquisition-of-all-intellectual-4b459 $5LB $BIOV $BVAXF.US
$BVAXF ($BIOV Canada). Cancer vaccines & delivery system. Just closed very sweet acquisition of all of IMV Inc intellectual property from IMV's secured creditor. IMV BK'd 2023. It has gone from 1 cent to about 6.5 cents over the last 2 months. "Crown Jewel" per COO Kenneth Kovan is DPX platform. States they are working to license out platform to other pharma. IMV was spending $20 million annually on R&D. CEO is James Passin former investment banker/deal maker type. I'm looking for a buyout by big pharma in the next 3 to 18 months. I don't see them in a position to resume IMV full R&D operations. Very much "under the radar". This will pop because of deals made to license DPX Platform, not retail. The "crown jewel" platform: https://youtu.be/Ub5Yuj-6010?si=-GOcCThoqelFC1OD https://www.investing.com/news/stock-market-news/biovaxys-acquires-imvs-immunotherapy-assets-and-ip-93CH-3301359 Interview with COO: https://cdn.jwplayer.com/previews/gR50sW5R
$Bvaxf $Biov posted this on X/Twitter At its peak, NASDAQ-listed IMV INC's market cap of US$0.33B and share price of US$59.50 reflects the high-value investors put on its technological innovations, pipeline & commercial potential. This historical benchmark projects potential capitalization for $BIOV $BVAXF post-acquisition.
Your post with title "$BVAXF Chart holding strong as the 50 Day ma is about to cross the 200 Day ma as it curls north..looks like a perfect storm brewing here.." has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*